Robert Gasser
Infectious Disease · Washington, DCNPI 1245324839
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $922,181 of the $922,181 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, AstraZeneca. Among infectious disease clinicians in DC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 6 payments — averaging $153,697 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$922K
What the payments were for
- Consulting fees$922,181100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 6 | $922,181 |
How this compares
$922,181 in reported general payments places this provider in the 95th percentile of 74 infectious disease providers in District of Columbia.
See all infectious disease providers in District of Columbia →
Other infectious disease in Washington
- Jesse GoodmanWashington$1.8M
- Theo HodgeWashington$1M
- Princy KumarWashington$270K
- Jose ChavezWashington$254K
- Linda NabhaWashington$60K
- Gebeyehu TeferiWashington$25K
- Jose BordonWashington$12K
- Rebecca KumarWashington$12K
- Jeffrey MurrayWashington$8K
- David DiemertWashington$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.